United States: Case Shows Ever-Changing Nature Of Patent Law

Last Updated: October 22 2016
Article by Clayton Zak

The America Invents Act (AIA), passed almost five years ago, continues to substantially change patent law in the United States — and questions about the law's effects are still being litigated. One important question currently being litigated before the Court of Appeals for the Federal Circuit is at the heart of Helsinn Healthcare SA v. Teva Pharmaceuticals USA Inc.

In that case, patent holder Helsinn reached an agreement to sell rights in a drug it had developed but was still testing more than a year before it filed a patent application on that drug. Helsinn used the money from the sale to complete testing and work on the drug. Helsinn's sale, however, did not result in any drug being available to the public. After the patent issued, Helsinn sued Teva for infringing its patent on the drug in question. Teva argued that the commercial sale of rights in the drug more than a year prior to the filing of the patent application barred Helsinn from obtaining a patent on the drug.

Prior to the AIA, this would have been a clear win for Teva. But, post-AIA, a Texas District Court ruled that the Helsinn patent was not invalidated by what would have historically been an on-sale bar. So how could this issue have recently been argued before the Court of Appeals for the Federal Circuit?

Does a secret sale of a product constitute prior art that can invalidate a patent?

Prior to the passage of the AIA, this question was well settled. Secret sales of a product were prior art that could be used to deny a patent as obvious or not new in light of the product secretly sold. For example, in Metallizing Eng'g Co. v. Kenyon Bearing & Auto Parts Co., 153 F.2d 516, 520 (2d Cir. 1946) the Court stated that "it is a condition upon an inventor's right to a patent that he shall not exploit his discovery competitively after it is ready for patenting; he must content himself with either secrecy, or legal monopoly." This precedent interpreted the Patent Act of 1952 which predated the AIA and stated:

A person shall be entitled to a patent unless . . . the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States.

Patent Act of 1952, 35 U.S.C. § 102(b). Underpinning the inclusion of secret sales within "on sale" is the idea that an inventor should not be able to hold an invention as a trade secret for a number of years, profit from the invention, and thereafter be granted a patent. This, if allowed, would essentially extend an inventor's patent monopoly beyond the specified term. Such a result would run counter to the purpose of the patent system, to promote the advancement of science by encouraging the public disclosure of inventions in exchange for a limited monopoly. Thus, the interpretation of "on sale" to include secret sales incentivized an inventor to more quickly file for a patent and disclose their invention.

But, the AIA changed the relevant language of 35 U.S.C. § 102:

A person shall be entitled to a patent unless . . . the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.

Before the Federal Circuit, Teva argued, consistent with the precedent described above, that Helsinn's secret sale more than one year prior to filing its patent application invalidated the patent asserted against Teva. Helsinn argued that the AIA changes to the statute required a sale to be public for the sale to be invalidating prior art.

The answer to the question — Does a secret sale constitute prior art under the AIA? — therefore turns on the interpretation of the AIA and congressional intent.

Helsinn's position, that only public sales constitute invalidating prior art, is premised primarily on the argument that the "otherwise available to the public" clause modifies the preceding "on sale clause." The catch all, "otherwise available to the public," indicates that all invalidating prior art must be available to the public. Thus, a secret sale cannot invalidate a patent.

The U.S. Patent and Trademark Office (PTO), supported Helsinn's interpretation of the statute, pointing to evidence of legislative intent to require invalidating sales to be public. In amicus briefing the PTO pointed out, among other legislative history, that during consideration of the AIA, "Senator Leahy explained that the language was 'drafted in part to do away with precedent under current law that private offers for sale or private uses . . . may be deemed patent-defeating prior art.' 157 Cong. Rec. S1496 (daily ed. Mar. 9, 2011) (statement of Sen. Leahy)." The PTO also argued that the policy underlying secret sales as prior art, to encourage patent filing, is furthered by the AIA's change to a first inventor to file system. The race to file a patent provided the incentive to file quickly, so the policy of including secret sales as prior art was no longer needed.

Teva, on the other hand, argued that the clause "otherwise available to the public" does not modify the preceding "on sale clause," and that Congress would have been more explicit in overruling decades of precedent. Congress could have stated "on public sale" or "on sale publicly" rather than rely on the residual clause "otherwise available to the public." Teva further asserted that the residual clause "otherwise available to the public" addresses communication not available during the drafting of the 1950's Patent Act such as the use of computers, tweets, and videotapes. Teva noted that "All of those things are now potentially within the publicly available clause because it just reaches anything that is otherwise publicly available."

Given the inherent vagaries of statutory construction, either side's arguments could persuade the court. As such, this case is a good illustration of the ever-changing nature of patent law and the importance of following best practices. Since the AIA change to a first-inventor-to-file system, it has been best practice to have a patent application on file before any disclosure, secret or public. If a patent application is on file before a secret or public sale, as consistent with current best practices, the Helsinn/Teva issues can be avoided.

Although the outcome of this case is important at the margins (e.g., maintaining secret sales as prior art makes it easier to invalidate patents) filing a patent application before any disclosure or commercialization is and remains the best practice. And make sure you talk to your patent counsel about any plans to license or sell technology prior to filing a patent application.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Shearman & Sterling LLP
Harness, Dickey & Pierce, P.L.C.
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Shearman & Sterling LLP
Harness, Dickey & Pierce, P.L.C.
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions